HLA-S - major histocompatibility complex, class I, S (pseudogene) Gene

Also Known as HLA-17

Species: Homo sapiens

Gene Type: pseudo
Gene ID: 267015

Related Diseases

Diseases Alias
Prolymphocytic Leukemia

  • Pll

  • Prolymphocytic Leukaemia

  • Leukemia Prolymphocytic

  • Leukemia, Prolymphocytic
Autoimmune Hepatitis

  • Aih

  • Hepatitis, Autoimmune

  • Autoimmune Chronic Active Hepatitis

  • Autoimmune Hepatitis With Centrilobular Necrosis

  • Autoimmune Chronic Hepatitis

  • Hepatitis Autoimmune
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B1455 Clindamycin Inhibitor 99.90% Yes
HY-N7118 Clindamycin hydrochloride monohydrate Inhibitor / Unkown
Bioactive MoleculesInhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99339 Tebentafusp 99.90% Unkown

Clinical Phase

Bioactive MoleculesInhibitory Antibodies (5)
Cat. No. Product Name Effect
Purity Phase
HY-P99573 Tebotelimab 99.52% Phase 3
HY-P99551 Tosatoxumab 95.00% Phase 3
HY-P990061 Polzastobart Inhibitor 97.81% Phase 2
HY-P991610 S-095029 Inhibitor / Phase 2
HY-P991366 IBI-397 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (94)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-161111 KVS0001 Inhibitor 99.14% Unkown
HY-P10493 NY-ESO-1 (157-165) peptide 99.75% Unkown
HY-150749A ODN D-SL03 sodium 98.57% Unkown
HY-P1826 CLIP (86-100) 98.39% Unkown
HY-P5425A Tetanus Toxin (830–844) TFA 96.13% Unkown
HY-P1745 InsB (9-23) Ligand 98.98% Unkown
HY-P11303 PADRE peptide Ligand 98.28% Unkown
HY-P1780A CEF20 TFA 99.32% Unkown
HY-103333 Arvanil 99.1% Unkown
HY-P5470 LMP2A (426-434) Inducer 96.09% Unkown
HY-157269 J10-1 99.92% Unkown
HY-N2245 Schisandrone Inhibitor 99.78% Unkown
HY-P10493A NY-ESO-1 (157-165) peptide TFA 97.62% Unkown
HY-P10664 EBV EBNA3B (416-424) Inhibitor 99.52% Unkown
HY-P1778A HPV16 E7 (86-93) TFA 98.01% Unkown
HY-P1919 [Asp371]-Tyrosinase (369-377), human 99.66% Unkown
HY-P3813 Tyrosinase (206-214), human 99.19% Unkown
HY-106187 MART-1 (27-35) (human) 98.60% Unkown
HY-173526 H052 Inhibitor 98.18% Unkown
HY-P1855 HER2/neu (654-662) GP2 98.26% Unkown
HY-P5475 BMLF1 (280–288) 98.19% Unkown
HY-RS06217 HLA-G Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-B1455S Clindamycin-d3 hydrochloride Inhibitor 99.62% Unkown
HY-106187B MART-1 (27-35) (human) TFA 98.12% Unkown
HY-138794B XL177B 99.36% Unkown
HY-150749 ODN D-SL03 Inducer 99.82% Unkown
HY-B1455S1 Clindamycin-13C,d3 Inhibitor 99.94% Unkown
HY-N10116A Calamenene / Unkown
HY-P11084 WT1 126-134 peptide 98.89% Unkown
HY-P11280A PRAME peptide (425-433) acetate Degrader 98.16% Unkown
HY-P11379 ELTLGEFLKL Modulator 99.42% Unkown
HY-P4032 HCV Peptide (35-44) 99.67% Unkown
HY-P5898 Z-Val-Val-Nle-diazomethylketone Inhibitor / Unkown
HY-RS06211 HLA-DRB1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-106156 Allotrap 07 / Unkown
HY-150740 ODN 21595 Inhibitor / Unkown
HY-159123 KHK-6 Inhibitor / Unkown
HY-176784 Human MOG-specifying DNA / Unkown
HY-180609 TCR-IN-2 Inhibitor / Unkown
HY-D3334 PE-CF594 / Unkown
HY-P10593 Influenza A NP (383-391) (HLA-B27) / Unkown
HY-P10662 HLA-B*0801-binding EBV peptide / Unkown
HY-P10663 EBV EBNA3A (379-387) / Unkown
HY-P10835 LAG-3 cyclic peptide inhibitor C25 Inhibitor / Unkown
HY-P10994 Eps8 peptide 327 / Unkown
HY-P11084A WT1 126-134 peptide acetate 99.12% Unkown
HY-P11089 TP53 neoepitope Substrate / Unkown
HY-P11090 TpD / Unkown
HY-P11127 MBP (111-129) / Unkown
HY-P11179 VTEHDTLLY / Unkown
HY-P11340 VMAPRTLFL Ligand / Unkown
HY-P11383 AIM2-derived decapeptide / Unkown
HY-P11390 BAGE (2-10) Ligand / Unkown
HY-P11434 Adipophilin-derived peptide Ligand / Unkown
HY-P11437 GFKQSSKAL Ligand / Unkown
HY-P11713 EBNA3B 399-408 / Unkown
HY-P11714 EBNA3 246-254 / Unkown
HY-P1700 BCMA72-80 / Unkown
HY-P1757 HIV p17 Gag (77-85) Inhibitor / Unkown
HY-P1778 HPV16 E7 (86-93) / Unkown
HY-P1780 CEF20 / Unkown
HY-P1835 CEF8, Influenza Virus NP (383-391) / Unkown
HY-P1857 CEF7, Influenza Virus NP (380-388) / Unkown
HY-P1881 HPV16-E711-20 epitope / Unkown
HY-P1890 CEF14, EBV Rta Protein (28-37) / Unkown
HY-P1901 Insulin alpha-chain (1-13) / Unkown
HY-P3248 J5 peptide / Unkown
HY-P3742 Tyrosinase (192-200), human mouse / Unkown
HY-P5294 YLLEMLWRL Inhibitor / Unkown
HY-P5478 Influenza virus PA (46-54) / Unkown
HY-P5482 Epstein-barr virus BRLF1 (134-142) / Unkown
HY-P5503 Pol (476-484), HIV-1 RT Epitope / Unkown
HY-RS06196 HLA-A Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06197 HLA-B Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06198 HLA-C Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06199 HLA-DMA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06200 HLA-DMB Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06201 HLA-DOA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06202 HLA-DOB Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06203 HLA-DPA1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06204 HLA-DPB1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06205 HLA-DQA1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06206 HLA-DQA2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06207 HLA-DQB1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06208 HLA-DQB2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06209 HLA-DQB3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06210 HLA-DRA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06212 HLA-DRB3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06213 HLA-DRB4 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06214 HLA-DRB5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06215 HLA-E Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06216 HLA-F Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-150740A ODN 21595 sodium Inhibitor / Unkown
HY-168384 M04 / Unkown
Bioactive MoleculesInhibitory Antibodies (14)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990832 Anti-MHC Class I Antibody (W6/32) Inhibitor 95.00% Unkown
HY-P990189 Anti-Monkey/Human MHC class II (HLA-DR) Antibody (L243) 95.00% Unkown
HY-P991750 Anti-pan MHC Class II (HLA II) Antibody (IVA12) Inhibitor 99.27% Unkown
HY-P990714 Obertamig Inhibitor 95.803% Unkown
HY-P992111 Elfritatug Inhibitor 98.98% Unkown
HY-P991590 1D09C3 / Unkown
HY-P992018 Anti-HLA-G Antibody Inhibitor / Unkown
HY-P992377 HY-0102 / Unkown
HY-P992388 IO-108 Inhibitor / Unkown
HY-P991247 Anti-HLA-A2 (Hu8F4) Inhibitor / Unkown
HY-P991787 Anti-HLA-A2 Antibody (BB7.2) Inhibitor / Unkown
HY-P991837 Anti-HLA-DP Antibody (B7/21) Inhibitor / Unkown
HY-P991844 Anti-HLA-DQ Antibody (1a3) Inhibitor / Unkown
HY-P992017 Anti-HLA-C Antibody Inhibitor / Unkown